InMed Pharmaceuticals (INM) Q2 2025 Earnings

13MayConfirmed
Q2 2024
Q4 2024
Q1 2025
Q2 2025
-3.64
-2.49
-1.33
-0.18

Details

Expected EPS
N/A
Actual EPS
-1.94
Surprise EPS
-1.94
Surprise Percent
+∞%

Description

InMed Pharmaceuticals (INM) has reported earnings of -1.94 per share for Q2 2025.

0 Comments

Share your thoughts